Web Results

Better Buy: Inovio Pharmaceuticals, Inc. vs. Incyte Corporation -- The ...

www.fool.com/investing/general/2016/02/16/better-buy-inovio-pharmaceuticals-inc-vs-incyte-co.aspx

Feb 16, 2016 ... Image source: Incyte Corporation. Recent weeks couldn't have been much better for Inovio Pharmaceuticals (NASDAQ:INO) -- and they ...

Better Buy: Inovio Pharmaceuticals, Inc. vs. Incyte Corporation -- The ...

www.fool.com/investing/2016/08/11/better-buy-inovio-pharmaceuticals-inc-vs-incyte-co.aspx

Aug 11, 2016 ... At first glance, the choice between Inovio Pharmaceuticals (NASDAQ:INO) and Incyte (NASDAQ:INCY) seems like a no-brainer for biotech ...

Incyte.com: Pharmaceutical Research | Product Development

www.incyte.com/

Incyte is a science-led biopharmaceutical research company specializing in oncology product development and innovative medicines that are used worldwide.

Investor Overview | Incyte.com

www.incyte.com/ir/investor-overview.aspx

Find information for investors for Incyte Corporation a company that is focused on Oncology product development and research.

Contact Us | Incyte.com

www.incyte.com/contact-us.aspx/

ir@incyte.com. Grant Inquiries grants.incyte.com · Legal Notice · Privacy · Cookies · Opt Out · Site Map. © 2012 — 2016 Incyte Corporation. All Rights Reserved.

Expanded Phase 1 Study of ABL001, a Potent, Allosteric Inhibitor of ...

www.bloodjournal.org/content/128/22/625

Dec 10, 2016 ... Rea: Ariad: Honoraria; BMS: Honoraria; Pfizer: Honoraria; Novartis: ... Talpaz: Incyte Corporation: Other: Travel expense reimbursement, ...

Examining the Clinical Features and Underlying Cardiovascular ...

www.bloodjournal.org/content/128/22/1934

Oh: Incyte Corporation: Membership on an entity's Board of Directors or advisory committees, Research Funding; Gilead: ... Delphine Rea et al., Blood , 2015.

Interim Analysis of the Myeloproliferative Disorders Research ...

www.bloodjournal.org/content/128/22/479

... Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera ..... Harrison: Baxaltra: Consultancy, Honoraria, Speakers Bureau; Incyte Corporation: Honoraria, Speakers Bureau; Gilead: ... Delphine Rea et al., Blood , 2015 ...